NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo a dramatic transformation. From the spire of One World Trade Center in Manhattan to the mist-shrouded Niagara Falls and the architectural heights of the Mactan-Cebu Airport in the Philippines, more than 325 landmarks will be bathed in a specific triad of colors: teal, green, and pink.
This coordinated display marks the ninth annual #LightUpMBC campaign, a global initiative spearheaded by METAvivor Research and Support. The event coincides with National Metastatic Breast Cancer (MBC) Awareness Day, a day dedicated to the only form of breast cancer that is currently terminal. While October is traditionally dominated by "pink ribbon" campaigns focused on early detection and survivorship, #LightUpMBC seeks to redirect the conversation toward the 30% of breast cancer patients whose disease spreads beyond the breast to vital organs, for whom there is no cure.
Main Facts: A Global Beacon for the "Invisible" Stage
The #LightUpMBC campaign is a massive logistical undertaking involving 195 cities across all 50 U.S. states and 20 countries. The scale of the 2026 event represents a record-breaking participation rate, signaling a growing international recognition of the specific needs of the metastatic community.
Metastatic breast cancer, also known as Stage 4, occurs when cancer cells break away from the primary tumor in the breast and travel through the lymphatic system or bloodstream to form new tumors in the bones, liver, lungs, or brain. Despite being the cause of nearly all breast cancer deaths, MBC research has historically received only a small fraction of overall breast cancer funding.
To bridge this gap, the #LightUpMBC campaign serves two primary purposes: visibility and fundraising. Every landmark illuminated represents a tribute to lives lost and a beacon of hope for those currently in treatment. Parallel to the physical light displays, the campaign anchors around "#LightUpMBC Live," a free virtual broadcast streaming at 8 p.m. ET. This year’s program, hosted by 11-year MBC survivor Tami Eagle Bowling and Broadway star Kara Lindsay, blends scientific education with high-caliber performances from Tony Award-winning artists like Victoria Clark and Dorian Harewood.
Crucially, the financial structure of the campaign is designed for maximum impact: 100% of the net proceeds are funneled directly into Stage 4 research grants. To date, the initiative has raised over $2.7 million, funding the very science that allows patients like Dr. Kelly Shanahan, METAvivor’s Board President, to live years beyond their initial prognosis.
Chronology: From a Single Bridge to a Global Phenomenon
The roots of #LightUpMBC are deeply personal, tracing back to a promise made between friends. In 2017, the campaign began as a singular, grassroots effort in Portsmouth, New Hampshire. Laura Inahara founded the movement in honor of her best friend, Jessica Moore, who was diagnosed with metastatic breast cancer at the age of 32 and passed away just four years later.
Jessica Moore’s final wish was modest: she wanted to see one local landmark lit in the colors of MBC awareness to help people understand that "pink" wasn’t the whole story. Inahara successfully petitioned the Memorial Bridge in Portsmouth to light up in 2017.
The timeline of the campaign’s growth reflects the power of digital advocacy:
- 2017: A single bridge in New Hampshire lights up; the #LightUpMBC hashtag is born.
- 2018–2019: The movement spreads across New England and the Tri-State area as patients and families begin petitioning their own local city halls and bridges.
- 2020: Despite the global pandemic, the campaign pivots to a virtual format. #LightUpMBC Live is launched, bringing the lights to people’s screens worldwide and significantly increasing the fundraising ceiling.
- 2021–2025: International expansion begins in earnest. Landmarks in Ireland, Canada, and the UK join the roster. The fundraising total crosses the $2 million mark.
- 2026: The campaign reaches a milestone of 325+ landmarks and 20 participating countries, cementing its status as the premier global event for MBC awareness.
Supporting Data: The Stark Reality of Stage 4
The urgency behind the #LightUpMBC campaign is underscored by harrowing statistics provided by the National Cancer Institute’s SEER (Surveillance, Epidemiology, and End Results) program. In 2026, an estimated 42,670 people in the United States alone are expected to die from breast cancer. This equates to approximately 117 deaths every single day.
Unlike early-stage breast cancer, which has a five-year survival rate of nearly 99% when localized, the five-year survival rate for metastatic disease hovers around 30%. However, these numbers are beginning to shift due to advances in targeted therapies and immunotherapies—advances that METAvivor helps fund.
The campaign’s symbolic colors—teal, green, and pink—carry specific meanings designed to differentiate MBC from the broader "pink" movement:
- Teal: Represents healing and spirituality.
- Green: Symbolizes the "triumph of spring over winter" and represents hope and renewal.
- Pink: Acknowledges the breast cancer origins of the disease.
The financial data also highlights a systemic disparity. Historically, less than 7% of all breast cancer research funding has been dedicated to the metastatic stage. METAvivor remains the only U.S. nonprofit that dedicates 100% of its research funding specifically to Stage 4. Since its inception, the organization has awarded millions in grants, focusing on how to stop the spread of cancer and how to manage it once it has metastasized.
Official Responses: Voices of Resilience and Science
The leadership of METAvivor emphasizes that while the lights are beautiful, the mission is survival. Dr. Kelly Shanahan, METAvivor Board President and a physician living with MBC since 2013, highlighted the cognitive dissonance many patients feel during Breast Cancer Awareness Month.
“When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan stated. “My hope and the hope of so many others lies in research. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community.”
Laura Inahara, the campaign’s founder, views the 2026 event as the ultimate realization of Jessica Moore’s legacy. “Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love,” Inahara said. She noted that the campaign has evolved into an educational platform, teaching patients how to advocate for their own treatment in a medical landscape that often treats Stage 4 as a "lost cause."
Tami Eagle Bowling, the Campaign Director and host of the live stream, emphasizes the importance of the "Live" component. By featuring patient stories alongside Tony-winning performers, the broadcast humanizes the statistics. "We are showing the world that we are here, we are living, and we are fighting for more time," Bowling remarked.
Implications: Shifting the Paradigm of Breast Cancer Advocacy
The success of #LightUpMBC suggests a significant shift in the culture of medical philanthropy. For decades, the "War on Cancer" focused almost exclusively on prevention and early detection. While these are vital, the #LightUpMBC movement highlights the "forgotten" population—those for whom early detection either failed or was never an option (as some are diagnosed metastatic from the start, known as de novo MBC).
The implications of this movement are threefold:
- Funding the "Hard" Science: By funneling millions into Stage 4 research, METAvivor is pushing the scientific community to focus on the mechanisms of metastasis—the very process that kills. This could eventually lead to MBC being managed as a chronic, rather than terminal, condition, similar to HIV/AIDS.
- Psychological Impact on Patients: The "Pink October" narrative can be isolating for those who will never "ring the bell" to signify the end of treatment. #LightUpMBC provides a counter-narrative of inclusion and validation.
- Policy and Public Awareness: As global landmarks like the Willis Tower and Philadelphia City Hall participate, the pressure on government bodies like the NIH to increase the percentage of funding for metastatic research grows. The visual "takeover" of city skylines makes the issue impossible for policymakers to ignore.
As October 13 approaches, the organizers urge the public to do more than just watch. They are calling for a "digital illumination"—asking supporters to photograph the landmarks and share them using the #LightUpMBC hashtag. In the world of Stage 4 cancer, where time is the most precious commodity, these lights serve as a reminder that for 117 people a day, the clock is ticking—and only research can slow it down.
For more information on participating landmarks or to view the #LightUpMBC Live stream on October 13 at 8 p.m. ET, visit www.lightupmbc.org.
About the Author
